FDA Accepts Supplement for ABSORICA LD by Sun Pharma
The FDA has accepted a supplemental application for ABSORICA LD, an isotretinoin product by Sun Pharma.
Asset / Drug
Drug and asset intelligence for Dermatology with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.